Skip to main content
. 2020 Feb 25;8(4):739–744. doi: 10.1002/ccr3.2735

Table 2.

Individual biochemistry at diagnosis and end of study (June 2019)

Patient no. Hb at dx Eos Hb Esr at dx Eos esr eGFR at dx Eos eGFR Ca at dx Eos ca B2M at dx Eos B2M
1 122 102 73 16 58 50 2.51 2.52 3.9 6.9
2 126 101 52 94 90 90 2.46 2.37 2.1 3.3
3 118 113 38 88 90 90 2.09 2.34 1.8 3
4 97 85 98 120 67 24 2.64 2.95 6.9 19.4
5 123 121 49 61 62 30 2.42 2.33 2.7 3.6
6 125 98 26 120 65 38 2.22 2.33 1.8 6.4
7 98 91 95 62 87 42 2.3 2.19 3.8 4.9
8 143 103 31 38 84 44 2.4 2.29 2.9 2.4
9 130 112 19 30 71 31 2.5 2.4 1.8 3.6
10 116 109 120 90 74 77 2.66 2.33 3.7 2.2
11 143 124 111 56 57 86 2.23 2.38 2.7 1.9
12 126 108 30 27 90 90 2.34 2.35 8.6 6.5
13 126 119 111 79 24 50 2.41 2.39 9.1 10.2
14 148 148 7 3 71 65 2.44 2.45 3.7 3.3
15 108 126 120 48 62 73 3.3 2.34 3 2.2

Abbreviations: B2M, beta 2 microglobulin (normal range 0‐3 mg/L); Ca, calcium (normal range 2.15‐2.55 mmol/L); dx, diagnosis; eGFR, estimated glomerular filtration rate (normal range > 90 mL/min); Eos, end of study; esr, erythrocyte sedimentation rate (normal range 0‐29 mm/h); Hb, hemoglobin (normal range 119‐160 g/L).